Sharecare the digital health company that helps people manage all their health in one place, today announced that its Board of Directors has completed the strategic review process initiated in August 2022.
After evaluating a number of alternatives with the support of advisors, the Board unanimously concluded that the best way to maximize value for shareholders at this time is to continue executing on the Company’s strategic plan to drive growth and efficiencies across all three of its complementary business channels. Highlighting its confidence in Sharecare’s long-term strategy and strong balance sheet and belief that the Company’s shares represent an attractive investment opportunity, the Board has re-authorized a $50 million stock repurchase program.
“The significant interest we received during our strategic review process not only confirmed the fundamental value of each of our business channels but, more importantly, that they are, in fact, all together better,” said Jeff Arnold, chairman and CEO of Sharecare. “Our complementary capabilities, data, unified platform, and expansive customer base deliver a differentiated ecosystem for our users and clients, as well as offered the best path forward to maximize value for our shareholders.”
As part of the review, Sharecare’s leadership also is executing an initiative to align and maximize synergies across the Company’s business channels to create integrated cross-sell opportunities, foster value-added, customer-centered relationships, and accelerate long-term revenue growth. This includes:
-
Sharecare’s Enterprise platform for comprehensive care solutions – which is currently focused on the employer, health plan, and government sectors – will be actively sold to new markets including health systems, life science companies, and other healthcare stakeholders by providing the Company’s connected care capabilities and extensive product portfolio via Sharecare’s flexible…
Read the full article here